Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for September 27th

Read MoreHide Full Article

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 27th:

Aclaris Therapeutics, Inc. (ACRS - Free Report) : This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.

Aclaris Therapeutics, Inc. Price and Consensus

Aclaris Therapeutics' shares gained 23% over the last one month compared to S&P 500’s rise of 4%. The company possesses a Momentum Score of A.

Aclaris Therapeutics, Inc. Price

American Electric Power (AEP - Free Report) : This electric public utility holding company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.

American Electric Power Company, Inc. Price and Consensus

American Electric Power's shares gained 4.3% over the last one month. The company possesses a Momentum Score of A.

American Electric Power Company, Inc. Price

Ally Financial Inc. (ALLY - Free Report) : This provider of financial products and services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.

Ally Financial Inc. Price and Consensus

Air Industries’ shares gained 10.2% over the last one month. The company possesses a Momentum Score of B.

Ally Financial Inc. Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Ally Financial Inc. (ALLY) - free report >>

American Electric Power Company, Inc. (AEP) - free report >>

Aclaris Therapeutics, Inc. (ACRS) - free report >>

Published in